Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,641 to 1,660 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protein signatures from blood plasma and urine suggest changes in vascular function and IL-12 signaling in elderly with a history of chronic diseases compared with an age-matched healthy cohort. | Geroscience | 2021 | 32974878 | PubTator, text mining | PubMed |
| Studying dynamics without explicit dynamics: A structure-based study of the export mechanism by AcrB. | Proteins | 2021 | 32960482 | PubTator, text mining | PubMed |
| Systematics for types and effects of RNA variations. | RNA Biol | 2021 | 32951567 | PubTator, text mining | PubMed |
| Personalized Medicine Using Cutting Edge Technologies for Genetic Epilepsies. | Curr Neuropharmacol | 2021 | 32933463 | PubTator, text mining | PubMed |
| Mesenchymal Stromal Cells in Viral Infections: Implications for COVID-19. | Stem Cell Rev Rep | 2021 | 32895900 | PubTator, text mining | PubMed |
| Molar mass effect in food and health. | Food Hydrocoll | 2021 | 32895590 | PubTator, text mining | PubMed |
| Reference range for C1-esterase inhibitor (C1 INH) in the third trimester of pregnancy. | J Perinat Med | 2021 | 32887189 | PubTator, text mining | PubMed |
| A Review of Neutrophil Extracellular Traps (NETs) in Disease: Potential Anti-NETs Therapeutics. | Clin Rev Allergy Immunol | 2021 | 32740860 | PubTator, text mining | PubMed |
| Successful Use of Recombinant Human C1-INH in a Patient with Acquired Angioedema due to C1 Inhibitor Deficiency and an Unusually High Titer of Anti-C1-Inhibitor Autoantibodies. | J Investig Allergol Clin Immunol | 2021 | 32732186 | PubTator, text mining | PubMed |
| Interplay between platelets and coagulation. | Blood Rev | 2021 | 32682574 | PubTator, text mining | PubMed |
| Tackling COVID-19 infection through complement-targeted immunotherapy. | Br J Pharmacol | 2021 | 32643798 | PubTator, text mining | PubMed |
| Fucose as a new therapeutic target in renal transplantation. | Pediatr Nephrol | 2021 | 32472330 | PubTator, text mining | PubMed |
| Characteristics of patients with C1 esterase inhibitor deficiency: a single center study. | Eur Ann Allergy Clin Immunol | 2021 | 32351099 | PubTator, text mining | PubMed |
| Nomograms combined with SERPINE1-related module genes predict overall and recurrence-free survival after curative resection of gastric cancer: a study based on TCGA and GEO data. | Transl Cancer Res | 2020 | 35117805 | PubTator, text mining | PubMed |
| Collagen family genes and related genes might be associated with prognosis of patients with gastric cancer: an integrated bioinformatics analysis and experimental validation. | Transl Cancer Res | 2020 | 35117235 | PubTator, text mining | PubMed |
| Rapid whole-exome sequencing facilitates precision medicine in paediatric rare disease patients and reduces healthcare costs. | Lancet Reg Health West Pac | 2020 | 34327338 | PubTator, text mining | PubMed |
| "Complimenting the Complement": Mechanistic Insights and Opportunities for Therapeutics in Hepatocellular Carcinoma. | Front Oncol | 2020 | 33718121 | PubTator, text mining | PubMed |
| New recessive mutations in SYT2 causing severe presynaptic congenital myasthenic syndromes. | Neurol Genet | 2020 | 33659639 | PubTator, text mining | PubMed |
| Progress and Clinical Application of Single-Cell Transcriptional Sequencing Technology in Cancer Research. | Front Oncol | 2020 | 33614479 | PubTator, text mining | PubMed |
| Integrative Analysis of Complement System to Prognosis and Immune Infiltrating in Colon Cancer and Gastric Cancer. | Front Oncol | 2020 | 33614473 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=83